Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
19.36
+0.05 (0.26%)
At close: Jan 23, 2026
Wuhan Easy Diagnosis Biomedicine Company Description
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China.
The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services.
It also provides information software and supporting hardware products. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
| Country | China |
| Founded | 2008 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 812 |
| CEO | Chen Li Li |
Contact Details
Address: East Lake New Technology Development Zone Wuhan, 430075 China | |
| Phone | 86 27 6552 3649 |
| Website | mdeasydiagnosis.com |
Stock Details
| Ticker Symbol | 002932 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000033Q7 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Chen Li Li | Chairman and GM |
| Wang Ying | Vice Chairman and Deputy GM |
| Rui Wang | Deputy GM, Chief Financial Officer and Board Secretary |
| Chaohui Li | Accounting Supervisor |